Neurogene has a $903M market cap with two phase 1/2 assets, NGN-401 for Rett Syndrome and NGN-101 for CLN5 Batten Disease.

The researchers described the extreme “pre-morbid” vulnerability of older hostages along with the additional data on their clinical situation and extreme stresses to which they are being subjected.

Big tech is on a building spree. Across America, companies are dumping billions into data centers—massive, climate-controlled ...

While both companies hold strong potential amid rising AI demand, AI models suggest that Nvidia stands out as the safer and ...